In a GRU exclusive series, Franklin Gaylis, MD, FACS, discusses how the urology field can use the electronic medical record, or EMR, to improve adherence to best medical practices in prostate cancer care.

- HOME
- MEETINGS
- AdMeTech Global Summit
- Future Directions in Urology Symposium
- Innovations in Urologic Practice
- International Bladder Cancer Expert Forum
- International Bladder Cancer Update
- International Prostate Cancer Update
- Perspectives in Urology: Point-Counterpoint
- Ralph E. Hopkins Urology Seminar
- Southwest Prostate Cancer Symposium
- Urology Today
- CONTENT & COMMENTARIES
- LEARNING CENTERS
- INDUSTRY PERSPECTIVE
- Industry Perspective: AR-V7 Testing for Men with Advanced Stage Prostate Cancer
- Industry Perspective: ConfirmMDx and Improving the Identification of Men at Risk for Clinically Significant Prostate Cancer
- Industry Perspective: The Oncotype DX Genomic Prostate Score Assay Test
- Industry Perspective: Panel Discussion on Cxbladder Genomic Urine Test for Bladder Cancer
- The Role of URO17™ in the Diagnosis and Management of Bladder Cancer
- Industry Perspective: Developing the Most Sensitive Urine Test for Bladder Cancer
- FACULTY
Select Page